Acadia Pharma (ACAD) Misses Q4 EPS by 1c; Offers FY23 Revenue Guidance
Go back to Acadia Pharma (ACAD) Misses Q4 EPS by 1c; Offers FY23 Revenue Guidance| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 28.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.24 | 52 Week High | $42.49 | |||
| Open | $28.24 | 52 Week Low | $16.64 | |||
| Day High | $28.24 | P/E | N/A | |||
| Day Low | $28.24 | EPS | $-0.42 | |||
| Volume | 10,886 | |||||
